| |
On-Tg ≥ 0.2 ng/ml (N = 30)
|
On-Tg < 0.2 ng/ml (N = 13)
|
t/χ2
|
P
|
|---|
|
Age, yrs
|
47.2 ± 14.5
|
38.0 ± 14.2
|
− 1.917
|
0.062
|
|
Sex (male)
|
12
|
4
|
0.054
|
0.817
|
|
BMI
|
23.4 ± 3.5
|
22.9 ± 3.3
|
− 0.417
|
0.679
|
|
NG
|
13
|
6
|
0.029
|
0.864
|
|
HD
|
4
|
1
|
< 0.001
|
0.990
|
|
Hypertension
|
3
|
1
|
< 0.001
|
1.000
|
|
Diabetes
|
1
|
1
|
–
|
0.518
|
|
Hyperthyroidism
|
2
|
0
|
–
|
1.000
|
|
Tumor size (primary), mm
|
22.6 ± 14.0
|
19.9.0 ± 11.8
|
− 0.594
|
0.556
|
|
Multifocality (primary)
|
2
|
5
|
4.597
|
0.032*
|
|
Bilatrality (primary)
|
2
|
2
|
0.110
|
0.740
|
|
Surgical strategy
|
|
iCND
|
0
|
0
|
–
|
–
|
|
bCND
|
6
|
3
|
–
|
–
|
|
bCND + iLND
|
17
|
9
|
–
|
0.385
|
|
bCND + bLND
|
7
|
1
|
–
|
0.385
|
|
Harvested LNs
|
38.4 ± 20.5
|
36.3 ± 22.3
|
− 0.300
|
0.766
|
|
Metastatic LNs
|
10.9 ± 9.4
|
6.2 ± 7.4
|
− 1.588
|
0.120
|
|
The ratio of metastatic LNs %
|
29.9 ± 24.0
|
19.1 ± 14.4
|
− 1.500
|
0.141
|
|
Diameter of recurrent LNs
|
23.6 ± 15.5
|
16.0 ± 4.7
|
− 2.438
|
0.020*
|
|
≥ 25 mm
|
13
|
0
|
6.151
|
0.013*
|
|
Extranodal extension
|
11
|
6
|
0.341
|
0.559
|
- BMI Body Mass Index, HD Hashimoto's disease, NG nodular goiter, iCND ipsilateral central neck dissection, bCND bilateral central neck dissection, iLND ipsilateral lateral neck dissection, bLND bilateral lateral neck dissection, LNs lymph nodes
- *Means significantly statistical differences
